Industry: Chemical & Material
Published Date: 2024-09-26
Pages: 149 Pages
Report ld: 3330992
Request Sample
Customized Report
Zofenapril calcium, as a commonly used drug, is widely used to treat cardiovascular diseases such as high blood pressure and heart failure. Zofenopril Calcium, the first thiol-containing third-generation long-acting angiotensin-converting enzyme inhibitor, is converted into the active efficent Zofenoprilat in vivo to exert its antihypertensive effect. Zofenapril calcium was developed by the Italian company Enarini and was first marketed in Italy and other countries in 2001.
The global Zofenopril Calcium market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Zofenopril Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Zofenopril Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Zofenopril Calcium is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Zofenopril Calcium include Midas Pharma, TCI AMERICA, Patsnap Synapse, Cayman Chemical, LGC Standards, Simson Pharma, Biosynth, USBio, Adooq Bioscience, Asia Bioscience, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Zofenopril Calcium production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Zofenopril Calcium by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
This report presents an overview of global market for Zofenopril Calcium, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Zofenopril Calcium, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Zofenopril Calcium, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Zofenopril Calcium sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Zofenopril Calcium market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Zofenopril Calcium sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Midas Pharma, TCI AMERICA, Patsnap Synapse, Cayman Chemical, LGC Standards, Simson Pharma, Biosynth, USBio, Adooq Bioscience, Asia Bioscience, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Zofenopril Calcium production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Zofenopril Calcium in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Zofenopril Calcium manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zofenopril Calcium sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Zofenopril Calcium Product Introduction
1.2 Market by Type
1.2.1 Global Zofenopril Calcium Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity ≥98%
1.2.3 Purity < 98%
1.3 Market by Application
1.3.1 Global Zofenopril Calcium Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Zofenopril Calcium Production
2.1 Global Zofenopril Calcium Production Capacity (2019-2030)
2.2 Global Zofenopril Calcium Production by Region: 2019 VS 2023 VS 2030
2.3 Global Zofenopril Calcium Production by Region
2.3.1 Global Zofenopril Calcium Historic Production by Region (2019-2024)
2.3.2 Global Zofenopril Calcium Forecasted Production by Region (2025-2030)
2.3.3 Global Zofenopril Calcium Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Zofenopril Calcium Revenue Estimates and Forecasts 2019-2030
3.2 Global Zofenopril Calcium Revenue by Region
3.2.1 Global Zofenopril Calcium Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Zofenopril Calcium Revenue by Region (2019-2024)
3.2.3 Global Zofenopril Calcium Revenue by Region (2025-2030)
3.2.4 Global Zofenopril Calcium Revenue Market Share by Region (2019-2030)
3.3 Global Zofenopril Calcium Sales Estimates and Forecasts 2019-2030
3.4 Global Zofenopril Calcium Sales by Region
3.4.1 Global Zofenopril Calcium Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Zofenopril Calcium Sales by Region (2019-2024)
3.4.3 Global Zofenopril Calcium Sales by Region (2025-2030)
3.4.4 Global Zofenopril Calcium Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufacturers
4.1 Global Zofenopril Calcium Sales by Manufacturers
4.1.1 Global Zofenopril Calcium Sales by Manufacturers (2019-2024)
4.1.2 Global Zofenopril Calcium Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Zofenopril Calcium in 2023
4.2 Global Zofenopril Calcium Revenue by Manufacturers
4.2.1 Global Zofenopril Calcium Revenue by Manufacturers (2019-2024)
4.2.2 Global Zofenopril Calcium Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Zofenopril Calcium Revenue in 2023
4.3 Global Zofenopril Calcium Sales Price by Manufacturers (2019-2024)
4.4 Global Key Players of Zofenopril Calcium, Industry Ranking, 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Zofenopril Calcium Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Zofenopril Calcium, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Zofenopril Calcium, Product Offered and Application
4.8 Global Key Manufacturers of Zofenopril Calcium, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Zofenopril Calcium Sales by Type
5.1.1 Global Zofenopril Calcium Historical Sales by Type (2019-2024)
5.1.2 Global Zofenopril Calcium Forecasted Sales by Type (2025-2030)
5.1.3 Global Zofenopril Calcium Sales Market Share by Type (2019-2030)
5.2 Global Zofenopril Calcium Revenue by Type
5.2.1 Global Zofenopril Calcium Historical Revenue by Type (2019-2024)
5.2.2 Global Zofenopril Calcium Forecasted Revenue by Type (2025-2030)
5.2.3 Global Zofenopril Calcium Revenue Market Share by Type (2019-2030)
5.3 Global Zofenopril Calcium Price by Type
5.3.1 Global Zofenopril Calcium Price by Type (2019-2024)
5.3.2 Global Zofenopril Calcium Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Zofenopril Calcium Sales by Application
6.1.1 Global Zofenopril Calcium Historical Sales by Application (2019-2024)
6.1.2 Global Zofenopril Calcium Forecasted Sales by Application (2025-2030)
6.1.3 Global Zofenopril Calcium Sales Market Share by Application (2019-2030)
6.2 Global Zofenopril Calcium Revenue by Application
6.2.1 Global Zofenopril Calcium Historical Revenue by Application (2019-2024)
6.2.2 Global Zofenopril Calcium Forecasted Revenue by Application (2025-2030)
6.2.3 Global Zofenopril Calcium Revenue Market Share by Application (2019-2030)
6.3 Global Zofenopril Calcium Price by Application
6.3.1 Global Zofenopril Calcium Price by Application (2019-2024)
6.3.2 Global Zofenopril Calcium Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Zofenopril Calcium Market Size by Type
7.1.1 US & Canada Zofenopril Calcium Sales by Type (2019-2030)
7.1.2 US & Canada Zofenopril Calcium Revenue by Type (2019-2030)
7.2 US & Canada Zofenopril Calcium Market Size by Application
7.2.1 US & Canada Zofenopril Calcium Sales by Application (2019-2030)
7.2.2 US & Canada Zofenopril Calcium Revenue by Application (2019-2030)
7.3 US & Canada Zofenopril Calcium Market Size by Country
7.3.1 US & Canada Zofenopril Calcium Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Zofenopril Calcium Revenue by Country (2019-2030)
7.3.3 US & Canada Zofenopril Calcium Sales by Country (2019-2030)
7.3.4 US
7.3.5 Canada
8 Europe
8.1 Europe Zofenopril Calcium Market Size by Type
8.1.1 Europe Zofenopril Calcium Sales by Type (2019-2030)
8.1.2 Europe Zofenopril Calcium Revenue by Type (2019-2030)
8.2 Europe Zofenopril Calcium Market Size by Application
8.2.1 Europe Zofenopril Calcium Sales by Application (2019-2030)
8.2.2 Europe Zofenopril Calcium Revenue by Application (2019-2030)
8.3 Europe Zofenopril Calcium Market Size by Country
8.3.1 Europe Zofenopril Calcium Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Zofenopril Calcium Sales by Country (2019-2030)
8.3.3 Europe Zofenopril Calcium Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Zofenopril Calcium Market Size by Type
9.1.1 China Zofenopril Calcium Sales by Type (2019-2030)
9.1.2 China Zofenopril Calcium Revenue by Type (2019-2030)
9.2 China Zofenopril Calcium Market Size by Application
9.2.1 China Zofenopril Calcium Sales by Application (2019-2030)
9.2.2 China Zofenopril Calcium Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Zofenopril Calcium Market Size by Type
10.1.1 Asia Zofenopril Calcium Sales by Type (2019-2030)
10.1.2 Asia Zofenopril Calcium Revenue by Type (2019-2030)
10.2 Asia Zofenopril Calcium Market Size by Application
10.2.1 Asia Zofenopril Calcium Sales by Application (2019-2030)
10.2.2 Asia Zofenopril Calcium Revenue by Application (2019-2030)
10.3 Asia Zofenopril Calcium Market Size by Region
10.3.1 Asia Zofenopril Calcium Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Zofenopril Calcium Revenue by Region (2019-2030)
10.3.3 Asia Zofenopril Calcium Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Zofenopril Calcium Market Size by Type
11.1.1 Middle East, Africa and Latin America Zofenopril Calcium Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Zofenopril Calcium Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Zofenopril Calcium Market Size by Application
11.2.1 Middle East, Africa and Latin America Zofenopril Calcium Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Zofenopril Calcium Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Zofenopril Calcium Market Size by Country
11.3.1 Middle East, Africa and Latin America Zofenopril Calcium Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Zofenopril Calcium Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Zofenopril Calcium Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profile
12.1 Midas Pharma
12.1.1 Midas Pharma Corporation Information
12.1.2 Midas Pharma Overview
12.1.3 Midas Pharma Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 Midas Pharma Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Midas Pharma Recent Developments
12.2 TCI AMERICA
12.2.1 TCI AMERICA Corporation Information
12.2.2 TCI AMERICA Overview
12.2.3 TCI AMERICA Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 TCI AMERICA Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 TCI AMERICA Recent Developments
12.3 Patsnap Synapse
12.3.1 Patsnap Synapse Corporation Information
12.3.2 Patsnap Synapse Overview
12.3.3 Patsnap Synapse Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Patsnap Synapse Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Patsnap Synapse Recent Developments
12.4 Cayman Chemical
12.4.1 Cayman Chemical Corporation Information
12.4.2 Cayman Chemical Overview
12.4.3 Cayman Chemical Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Cayman Chemical Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Cayman Chemical Recent Developments
12.5 LGC Standards
12.5.1 LGC Standards Corporation Information
12.5.2 LGC Standards Overview
12.5.3 LGC Standards Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 LGC Standards Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 LGC Standards Recent Developments
12.6 Simson Pharma
12.6.1 Simson Pharma Corporation Information
12.6.2 Simson Pharma Overview
12.6.3 Simson Pharma Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Simson Pharma Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Simson Pharma Recent Developments
12.7 Biosynth
12.7.1 Biosynth Corporation Information
12.7.2 Biosynth Overview
12.7.3 Biosynth Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Biosynth Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Biosynth Recent Developments
12.8 USBio
12.8.1 USBio Corporation Information
12.8.2 USBio Overview
12.8.3 USBio Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.8.4 USBio Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 USBio Recent Developments
12.9 Adooq Bioscience
12.9.1 Adooq Bioscience Corporation Information
12.9.2 Adooq Bioscience Overview
12.9.3 Adooq Bioscience Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.9.4 Adooq Bioscience Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Adooq Bioscience Recent Developments
12.10 Asia Bioscience
12.10.1 Asia Bioscience Corporation Information
12.10.2 Asia Bioscience Overview
12.10.3 Asia Bioscience Zofenopril Calcium Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.10.4 Asia Bioscience Zofenopril Calcium Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Asia Bioscience Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Zofenopril Calcium Industry Chain Analysis
13.2 Zofenopril Calcium Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Zofenopril Calcium Production Mode & Process
13.4 Zofenopril Calcium Sales and Marketing
13.4.1 Zofenopril Calcium Sales Channels
13.4.2 Zofenopril Calcium Distributors
13.5 Zofenopril Calcium Customers
14 Zofenopril Calcium Market Dynamics
14.1 Zofenopril Calcium Industry Trends
14.2 Zofenopril Calcium Market Drivers
14.3 Zofenopril Calcium Market Challenges
14.4 Zofenopril Calcium Market Restraints
15 Key Findings in the Global Zofenopril Calcium Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Zofenopril Calcium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 141
USD 4900.00
(Single User License)
The global Zofenopril Calcium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 80
USD 4250.00
(Single User License)
The global market for Zofenopril Calcium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 103
USD 3950.00
(Single User License)
The global Zofenopril Calcium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 134
USD 2900.00
(Single User License)
The global Zofenopril Calcium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 137
USD 4900.00
(Single User License)
The global Zofenopril Calcium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 80
USD 4250.00
(Single User License)
The global market for Zofenopril Calcium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 101
USD 3950.00
(Single User License)
The global market for Zofenopril Calcium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 95
USD 2900.00
(Single User License)
Zofenapril calcium, as a commonly used drug, is widely used to treat cardiovascular diseases such as high blood pressure and heart failure. Zofenopril Calcium, the first thiol-containing third-generation long-acting angiotensin-converting enzyme inhibitor, is converted into the active efficent Zofenoprilat in vivo to exert its antihypertensive effect. Zofenapril calcium was developed by the Italian company Enarini and was first marketed in Italy and other countries in 2001.
Published Date: 2024-09-26
Pages: 88
USD 2900.00
(Single User License)
Zofenapril calcium, as a commonly used drug, is widely used to treat cardiovascular diseases such as high blood pressure and heart failure. Zofenopril Calcium, the first thiol-containing third-generation long-acting angiotensin-converting enzyme inhibitor, is converted into the active efficent Zofenoprilat in vivo to exert its antihypertensive effect. Zofenapril calcium was developed by the Italian company Enarini and was first marketed in Italy and other countries in 2001.
Published Date: 2024-09-26
Pages: 114
USD 4350.00
(Single User License)
The global Zofenopril Calcium market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 141
The global Zofenopril Calcium market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 80
The global market for Zofenopril Calcium was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 103
The global Zofenopril Calcium market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 134
The global Zofenopril Calcium market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 137
The global Zofenopril Calcium market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 80
The global market for Zofenopril Calcium was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 101
The global market for Zofenopril Calcium was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 95
Zofenapril calcium, as a commonly used drug, is widely used to treat cardiovascular diseases such as high blood pressure and heart failure. Zofenopril Calcium, the first thiol-containing third-generation long-acting angiotensin-converting enzyme inhibitor, is converted into the active efficent Zofenoprilat in vivo to exert its antihypertensive effect. Zofenapril calcium was developed by the Italian company Enarini and was first marketed in Italy and other countries in 2001.
Published: 2024-09-26
Pages: 88
Zofenapril calcium, as a commonly used drug, is widely used to treat cardiovascular diseases such as high blood pressure and heart failure. Zofenopril Calcium, the first thiol-containing third-generation long-acting angiotensin-converting enzyme inhibitor, is converted into the active efficent Zofenoprilat in vivo to exert its antihypertensive effect. Zofenapril calcium was developed by the Italian company Enarini and was first marketed in Italy and other countries in 2001.
Published: 2024-09-26
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now